Jorge Alberto Sandoval-Luna
Research Subjects
Jorge Alberto Sandoval-Luna has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alex Rivera-Toquica
Servicio de Cardiología, Clínica los Rosales Pereira Colombia
1 shared publication - Alexis del Carmen Llamas Jiménez
Clínica Las Américas, Medellín, Colombia
1 shared publication - Andrés Buitrago
Departamento de Medicina Interna, Fundación Santa Fe de Bogotá, Bogotá, Colombia; Departamento de Medicina Interna, Universidad de Los Andes, Bogotá, Colombia
1 shared publication - Clara Saldarriaga
Departamento de Cardiología, Clínica Cardio VID, Medellín, Colombia; Departamento de Cardiología, Universidad de Antioquia, Medellín, Colombia; Departamento de Cardiología, Universidad Pontificia Bolivariana, Medellín, Colombia
1 shared publication - Erika Martínez Carreño
Cardiologia, Clinica Iberoamerica UCAD, Barranquilla-Atlántico 080001, Colombia
1 shared publication - Gustavo Adolfo Moreno-Silgado
Departamento de Cardiología, Hospicardio, Montería, Colombia
1 shared publication
Latest Publications
- Open Access
- 31 May 2024
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 44 (Sp. 1) , 182-197
Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)
Introduction. Heart failure and type 2 diabetes mellitus are critical public health issues.Objective. To characterize the risk factors for mortality in patients with heart failure and type 2 diabetes mellitus from a large registry in Colombia and to evaluate the potential effect modifications by type 2 diabetes mellitus over other risk factors.Materials and methods. Heart failure patients with and without type 2 diabetes mellitus enrolled in the Registro Colombiano de Falla Cardíaca (RECOLFACA) were included. RECOLFACA enrolled adult patients with heart failure diagnosis from 60 medical centers in Colombia during 2017-2019. The primary outcome was all-cause mortality. Survival analysis was performed using adjusted Cox proportional hazard models.Results. A total of 2514 patients were included, and the prevalence of type 2 diabetes mellitus was 24.7% (n = 620). We found seven independent predictors of short-term mortality for the general cohort, chronic obstructive pulmonary disease, sinus rhythm, triple therapy, nitrates use, statins use, anemia, and hyperkalemia. In the type 2 diabetes mellitus group, only the left ventricle diastolic diameter was an independent mortality predictor (HR = 0.96; 95% CI: 0.93-0.98). There was no evidence of effect modification by type 2 diabetes mellitus on the relationship between any independent predictors and all-cause mortality. However, a significant effect modification by type 2 diabetes mellitus between smoking and mortality was observed.Conclusions. Patients with type 2 diabetes mellitus had higher mortality risk. Our results also suggest that type 2 diabetes mellitus diagnosis does not modify the effect of the independent risk factors for mortality in heart failure evaluated. However, type 2 diabetes mellitus significantly modify the risk relation between mortality and smoking in patients with heart failure.
- 31 May 2024
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 44 (Sp. 1) , 182-197
Open AccessDiabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)
Introduction. Heart failure and type 2 diabetes mellitus are critical public health issues.Objective. To characterize the risk factors for mortality in patients with heart failure and type 2 diabetes mellitus from a large registry in Colombia and to evaluate the potential effect modifications by type 2 diabetes mellitus over other risk factors.Materials and methods. Heart failure patients with and without type 2 diabetes mellitus enrolled in the Registro Colombiano de Falla Cardíaca (RECOLFACA) were included. RECOLFACA enrolled adult patients with heart failure diagnosis from 60 medical centers in Colombia during 2017-2019. The primary outcome was all-cause mortality. Survival analysis was performed using adjusted Cox proportional hazard models.Results. A total of 2514 patients were included, and the prevalence of type 2 diabetes mellitus was 24.7% (n = 620). We found seven independent predictors of short-term mortality for the general cohort, chronic obstructive pulmonary disease, sinus rhythm, triple therapy, nitrates use, statins use, anemia, and hyperkalemia. In the type 2 diabetes mellitus group, only the left ventricle diastolic diameter was an independent mortality predictor (HR = 0.96; 95% CI: 0.93-0.98). There was no evidence of effect modification by type 2 diabetes mellitus on the relationship between any independent predictors and all-cause mortality. However, a significant effect modification by type 2 diabetes mellitus between smoking and mortality was observed.Conclusions. Patients with type 2 diabetes mellitus had higher mortality risk. Our results also suggest that type 2 diabetes mellitus diagnosis does not modify the effect of the independent risk factors for mortality in heart failure evaluated. However, type 2 diabetes mellitus significantly modify the risk relation between mortality and smoking in patients with heart failure.